These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3263035)

  • 1. Abnormal myocardial fatty acid metabolism in dilated cardiomyopathy detected by iodine-123 phenylpentadecanoic acid and tomographic imaging.
    Ugolini V; Hansen CL; Kulkarni PV; Jansen DE; Akers MS; Corbett JR
    Am J Cardiol; 1988 Nov; 62(13):923-8. PubMed ID: 3263035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iodine-123 phenylpentadecanoic acid and single photon emission computed tomography in identifying left ventricular regional metabolic abnormalities in patients with coronary heart disease: comparison with thallium-201 myocardial tomography.
    Hansen CL; Corbett JR; Pippin JJ; Jansen DE; Kulkarni PV; Ugolini V; Henderson E; Akers M; Buja LM; Parkey RW
    J Am Coll Cardiol; 1988 Jul; 12(1):78-87. PubMed ID: 3259960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine-123 phenylpentadecanoic acid myocardial scintigraphy in patients with left ventricular hypertrophy: alterations in left ventricular distribution and utilization.
    Wolfe CL; Kennedy PL; Kulkarni PV; Jansen DE; Gabliani GI; Corbett JR
    Am Heart J; 1990 Jun; 119(6):1338-47. PubMed ID: 2141221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course.
    Yazaki Y; Isobe M; Takahashi W; Kitabayashi H; Nishiyama O; Sekiguchi M; Takemura T
    Heart; 1999 Feb; 81(2):153-9. PubMed ID: 9922350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [123I]-phenylpentadecanoic acid uptake in patients with dilated cardiomyopathy.
    Miche E; Radzewitz A; Notohamiprodjo G; Baller D; Kloppe A; Eckert S; Gleichmann U
    Eur J Heart Fail; 2002 Aug; 4(4):431-8. PubMed ID: 12167380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-nuclide study of the myocardium using 201Tl and 123I-labeled fatty acids in non-ischemic myocardial diseases.
    Knapp WH; Vyska K; Machulla HJ; Notohamiprodjo G; Schmidt U; Knust EJ; Gleichmann U
    Nuklearmedizin; 1988 Jun; 27(3):72-8. PubMed ID: 3405780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reduced myocardial fatty acid utilization in coronary heart disease following symptom limited ergometric stress. Detection of pathologic metabolic patterns using iodine-123-phenylpentadecanoic acid and sequential SPECT].
    Reske SN; Nitsch J; von der Lohe E; Simon HJ; Bardos P; Büll U
    Z Kardiol; 1989 Apr; 78(4):262-70. PubMed ID: 2786661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myocardial scintigraphy with iodine 123-labeled fatty acids].
    Dudczak R
    Wien Klin Wochenschr Suppl; 1983; 143():3-35. PubMed ID: 6228070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of myocardial perfusion and metabolic interventions on cardiac kinetics of phenylpentadecanoic acid (IPPA) I 123.
    Reske SN; Schön S; Schmitt W; Machulla HJ; Knopp R; Winkler C
    Eur J Nucl Med; 1986; 12 Suppl():S27-31. PubMed ID: 3490375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
    Visser FC
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creatine depletion and altered fatty acid metabolism in diseased human hearts: clinical investigation using 1H magnetic resonance spectroscopy and 123I BMIPP myocardial scintigraphy.
    Nakae I; Mitsunami K; Matsuo S; Horie M
    Acta Radiol; 2007 May; 48(4):436-43. PubMed ID: 17453526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy.
    Henderson EB; Kahn JK; Corbett JR; Jansen DE; Pippin JJ; Kulkarni P; Ugolini V; Akers MS; Hansen C; Buja LM
    Circulation; 1988 Nov; 78(5 Pt 1):1192-9. PubMed ID: 3180378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in fatty acid metabolism in dilated cardiomyopathy and hypertrophic cardiomyopathy in childhood].
    Thies WR; Vyska K; Matthies W; Notohamiprodjo G; Knapp W; Meyer H
    Wien Klin Wochenschr; 1989 Jan; 101(1):8-11. PubMed ID: 2913726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of improvement in left ventricular function with iodine-123-IPPA after coronary revascularization.
    Hansen CL; Heo J; Oliner C; Van Decker W; Iskandrian AS
    J Nucl Med; 1995 Nov; 36(11):1987-93. PubMed ID: 7472586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of myocardial ischemia by gallopamil: a dual-isotope study with thallium-201 and iodine-123 phenylpentadecanoic acid.
    Zimmermann R; Tillmanns H; Kapp M; Grethe U; Neumann FJ; Schlumpp K; Rauch B; Bubeck B; Kübler W
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S40-7. PubMed ID: 1284156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary report of an ongoing phase I/II dose range, safety and efficacy study of iodine-123-phenylpentadecanoic acid for the identification of viable myocardium.
    Hansen CL
    J Nucl Med; 1994 Apr; 35(4 Suppl):38S-42S. PubMed ID: 8151411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo esterification of a synthetic 125I-labeled fatty acid into cardiac glycerolipids.
    Chien KR; Han A; White J; Kulkarni P
    Am J Physiol; 1983 Oct; 245(4):H693-7. PubMed ID: 6624940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodine 123-phenylpentadecanoic acid myocardial scintigraphy: usefulness in the identification of myocardial ischemia.
    Kennedy PL; Corbett JR; Kulkarni PV; Wolfe CL; Jansen DE; Hansen CL; Buja LM; Parkey RW; Willerson JT
    Circulation; 1986 Nov; 74(5):1007-15. PubMed ID: 3769161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial viability assessment with dynamic low-dose iodine-123-iodophenylpentadecanoic acid metabolic imaging: comparison with myocardial biopsy and reinjection SPECT thallium after myocardial infarction.
    Murray GL; Schad NC; Magill HL; Vander Zwaag R
    J Nucl Med; 1994 Apr; 35(4 Suppl):43S-48S. PubMed ID: 8151413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
    Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK
    J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.